<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Lane Slot | Activity</title>
	<link>https://recash.wpsoul.net/members/bobcatfan7/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/bobcatfan7/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Lane Slot.</description>
	<lastBuildDate>Wed, 20 May 2026 00:51:16 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">39591b2eb41980fd19c287289bf8c3c4</guid>
				<title>Lane Slot posted an update: Infusions of epinephrine titrated to treat unstable [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/54497/</link>
				<pubDate>Wed, 11 Dec 2024 20:53:28 +0000</pubDate>

									<content:encoded><![CDATA[<p>Infusions of epinephrine titrated to treat unstable hypotension, as well as potassium for severe hypokalemia may be required. Current scientific evidence does not support treatment or prophylactic use of these agents for COVID-19 disease. Regulatory and public health authorities recognize that CQ/HCQ may offer little clinical benefit and only add&hellip;<span class="activity-read-more" id="activity-read-more-54497"><a href="https://recash.wpsoul.net/activity/p/54497/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9919631ff627f4532d3c47ab0733ebcc</guid>
				<title>Lane Slot became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/54283/</link>
				<pubDate>Wed, 11 Dec 2024 20:34:32 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>